Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Bortezomib Patent Expiration

Bortezomib is Used for treating multiple myeloma patients who have not responded to previous therapies. It was first introduced by Takeda Pharmaceuticals Usa Inc in its drug Velcade on May 13, 2003. Another drug containing Bortezomib is Bortezomib. 22 different companies have introduced drugs containing Bortezomib.


Bortezomib Patents

Given below is the list of patents protecting Bortezomib, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Bortezomib US11679119 Bortezomib compositions Sep 23, 2042 Maia Pharms Inc
Bortezomib US11752164 Bortezomib compositions Sep 23, 2042 Maia Pharms Inc
Bortezomib US12005069 Bortezomib compositions Sep 23, 2042 Maia Pharms Inc
Bortezomib US8962572 Bortezomib formulations Nov 03, 2032 Fresenius Kabi Usa
Velcade US6713446

(Pediatric)

 Formulation of boronic acid compounds Jul 25, 2022

(Expired)

 Takeda Pharms Usa
Velcade US6958319

(Pediatric)

 Formulation of boronic acid compounds Jul 25, 2022

(Expired)

 Takeda Pharms Usa
Velcade US6713446 Formulation of boronic acid compounds Jan 25, 2022

(Expired)

 Takeda Pharms Usa
Velcade US6958319 Formulation of boronic acid compounds Jan 25, 2022

(Expired)

 Takeda Pharms Usa
Velcade US5780454

(Pediatric)

 Boronic ester and acid compounds Nov 03, 2017

(Expired)

 Takeda Pharms Usa
Velcade US5780454 Boronic ester and acid compounds May 03, 2017

(Expired)

 Takeda Pharms Usa
Velcade US6083903 Boronic ester and acid compounds, synthesis and uses Oct 28, 2014

(Expired)

 Takeda Pharms Usa
Velcade US6297217 Boronic ester and acid compounds, synthesis and uses Oct 28, 2014

(Expired)

 Takeda Pharms Usa
Velcade US6617317 Boronic ester and acid compositions Oct 28, 2014

(Expired)

 Takeda Pharms Usa
Velcade US6747150 Boronic ester and acid compounds, synthesis and uses Oct 28, 2014

(Expired)

 Takeda Pharms Usa
Velcade US7119080 Boronic ester and acid compounds, synthesis and uses Oct 28, 2014

(Expired)

 Takeda Pharms Usa



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Bortezomib's patents.

Given below is the list recent legal activities going on the following patents of Bortezomib.

Activity Date Patent Number
Patent litigations
Patent eGrant Notification 12 Sep, 2023 US11752164
Patent Issue Date Used in PTA Calculation
Critical
 12 Sep, 2023 US11752164
Recordation of Patent eGrant 12 Sep, 2023 US11752164
Recordation of Patent Grant Mailed
Critical
 12 Sep, 2023 US11752164
Mail Patent eGrant Notification 12 Sep, 2023 US11752164
Email Notification
Critical
 12 Sep, 2023 US11752164
Email Notification
Critical
 24 Aug, 2023 US11752164
Issue Notification Mailed
Critical
 23 Aug, 2023 US11752164
Electronic Review
Critical
 10 Aug, 2023 US11752164
Email Notification
Critical
 10 Aug, 2023 US11752164


Bortezomib's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Bortezomib Generic API Manufacturers

Several generic applications have been filed for Bortezomib. The first generic version for Bortezomib was by Fresenius Kabi Usa Llc and was approved on May 2, 2022. And the latest generic version is by Hetero Labs Ltd Unit Vi and was approved on May 3, 2024.

Given below is the list of companies who have filed for Bortezomib generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Discontinued INTRAVENOUS, SUBCUTANEOUS N/A Jul 26, 2022





2. APOTEX

Apotex Inc has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Prescription INTRAVENOUS, SUBCUTANEOUS AP May 2, 2022


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Toronto Apotex Inc.
Brantford Apotex Pharmachem Inc.
Etobicoke Apotex, Inc.
Winnipeg Apotex Fermentation Inc.
North York Apotex Inc.
Richmond Hill Apotex Inc.
India
Bangalore Apotex Pharmachem India Pvt Ltd.
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bengaluru Apotex Research Private Limited





3. BAXTER HLTHCARE CORP

Baxter Healthcare Corp has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Baxter Hlthcare Corp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Prescription INTRAVENOUS, SUBCUTANEOUS AP May 2, 2022





4. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Prescription INTRAVENOUS, SUBCUTANEOUS AP Jul 26, 2022





5. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Prescription INTRAVENOUS, SUBCUTANEOUS AP May 2, 2022


Manufacturing Plant Locations
New

Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.

Country City Firm Name
India
Riico Industrial Area EUGIA Pharma Specialities Limited
Pashamylaram Eugia Pharma Specialities Limited
Medchal-Malkajgiri District EUGIA Pharma Specialities Limited





6. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Prescription INTRAVENOUS, SUBCUTANEOUS AP May 2, 2022


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Bensenville Fresenius Kabi USA LLC (FK USA)
Skokie Fresenius Kabi USA LLC
North Andover Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA LLC
Melrose Park Fresenius Kabi USA, LLC
Lake Zurich Fresenius Kabi USA, LLC
Wilson Fresenius Kabi USA, LLC
Grand Island Fresenius Kabi USA, LLC





7. HETERO LABS LTD VI

Hetero Labs Ltd Unit Vi has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Vi.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Prescription INTRAVENOUS, SUBCUTANEOUS AP May 3, 2024





8. HOSPIRA

Hospira Inc has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Prescription INTRAVENOUS, SUBCUTANEOUS AP Jul 26, 2022


Manufacturing Plant Locations
New

Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.

Country City Firm Name
Australia
Mulgrave Hospira Australia Pty Ltd.
United States
Lake Forest Hospira Inc
Clayton Hospira, Inc.
Pleasant Prairie Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company
Morgan Hill Hospira Inc
Mcpherson Hospira, Inc., A Pfizer Company
Rocky Mount Hospira, Inc.
Dominican Republic (the)
Haina, San Cristobal Hospira, Ltd.





9. JIANGSU HANSOH PHARM

Jiangsu Hansoh Pharmaceutical Group Co Ltd has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Jiangsu Hansoh Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Prescription INTRAVENOUS, SUBCUTANEOUS AP Jul 26, 2022


Manufacturing Plant Locations
New

Jiangsu Hansoh Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Jiangsu Hansoh Pharm as present at those locations.

Country City Firm Name
China
Lianyungang Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Lianyungang Jiangsu Hansoh Pharmaceutical Group Co., Ltd





10. MEITHEAL

Meitheal Pharmaceuticals Inc has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Meitheal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Prescription INTRAVENOUS, SUBCUTANEOUS AP Jul 26, 2022





11. MSN

Msn Laboratories Private Ltd has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Msn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Prescription INTRAVENOUS, SUBCUTANEOUS AP Jul 26, 2022


Manufacturing Plant Locations
New

Msn's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Msn as present at those locations.

Country City Firm Name
India
Kamareddy MSN Life Sciences Private Limited
Sangareddy MSN Pharmachem Private Limited
Rangareddy District MSN Laboratories Private Limited
Sangareddy MSN Laboratories Private Limited, R&D Center
Medak MSN LIFE SCIENCES PRIVATE LIMITED
Yadadri Bhuvanagiri District MSN Organics Private Limited
Rangareddy District MSN Laboratories Private Limited (Formulations Division, Unit-II)
Sangareddy MSN Laboratories Private Ltd.
Isnapur MSN Laboratories Private Limited, Unit-II
Jinnaram, Sangareddy MSN Laboratories Private Limited - Formulations Division
United States
Piscataway MSN PHARMACEUTICALS INC





12. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Discontinued INTRAVENOUS, SUBCUTANEOUS N/A Oct 31, 2022





13. PHARMASCIENCE INC

Pharmascience Inc has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Pharmascience Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Prescription INTRAVENOUS, SUBCUTANEOUS AP May 2, 2022


Manufacturing Plant Locations
New

Pharmascience Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Pharmascience Inc as present at those locations.

Country City Firm Name
Canada
Montreal Pharmascience Inc.
La Prairie Pharmascience Inc.





14. QILU PHARM HAINAN

Qilu Pharmaceutical Hainan Co Ltd has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Qilu Pharm Hainan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Prescription INTRAVENOUS, SUBCUTANEOUS AP May 2, 2022





15. RELIANCE LIFE SCI

Reliance Life Sciences Private Ltd has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Reliance Life Sci.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Prescription INTRAVENOUS, SUBCUTANEOUS AP Oct 11, 2022


Manufacturing Plant Locations
New

Reliance Life Sci's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Reliance Life Sci as present at those locations.

Country City Firm Name
India
Navi Mumbai Reliance Life Sciences Private Limited





16. SANDOZ

Sandoz Inc has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Prescription INTRAVENOUS, SUBCUTANEOUS AP Jul 26, 2022


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Langkampfen Sandoz GmbH
Kundl Sandoz GmbH
United States
Princeton Sandoz Inc
East Hanover Sandoz Incorporated
Spain
Les Franqueses Del Valles Sandoz Industrial Products S.A.
Palafolls Sandoz Industrial Products, S.A.
India
Navi Mumbai Sandoz Private Limited





17. SCINOPHARM TAIWAN

Scinopharm Taiwan Ltd has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Scinopharm Taiwan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Discontinued INTRAVENOUS, SUBCUTANEOUS N/A Sep 26, 2023


Manufacturing Plant Locations
New

Scinopharm Taiwan's manufacturing plants are situated in 1 country - Taiwan. Given below are the details of these plant locations as well as the firm names of Scinopharm Taiwan as present at those locations.

Country City Firm Name
Taiwan
Tainan City Scinopharm Taiwan Ltd





18. TEVA PHARMS USA

Teva Pharmaceuticals Usa Inc has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Discontinued INTRAVENOUS, SUBCUTANEOUS N/A May 2, 2022





19. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Bortezomib. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG/VIAL

injectable Prescription INTRAVENOUS, SUBCUTANEOUS AP May 2, 2022